LSHTM/UCL World TB day symposium 2017 – videos are available now


On the 24th of March, the world commemorates the day in 1882 that Dr Robert Koch announced his discovery of Mycobacterium tuberculosis. We take this opportunity each year to highlight contemporary research innovation and future challenges in a one day symposium co-organised by the LSHTM TB Centre and UCL-TB.

This year’s symposium took place at the Institute of Child Health, 30 Guilford Street, London.

You can view the videos from the symposium here:


Peter Piot (LSHTM) and David Lomas (UCL) Video address by Mario Raviglione (WHO)

Session 1: What is the natural history of TB? (full session video)

Mahdad Noursadeghi (UCL, chair)

Hanif Esmail (Oxford) ‘Early events in pulmonary TB’

Tim McHugh (UCL) ‘Fat, lazy and indifferent – the response of tubercle bacilli to treatment’

Tom Sumner (LSHTM) ‘Tests for risk of progression: modelling the population level impact’

Gabriele Pollara (UCL) ‘Disease status affects the human immune response to TB’

Full panel Q&A session: What is the natural history of TB?

Session 2: Is there sexism in TB? (full session video)

Helen Fletcher (LSHTM, chair)

Charalampos Sismanidis (WHO) ‘Disaggregate and conquer: the role of TB surveillance and surveys in ending the epidemic’

Lisa Stockdale (LSHTM) ‘Sex differences in immune correlates of TB risk’

Michael Murphy (UCL) ‘The Fairer Sex? Why women did better in the REMox Study’

Katherine Horton (LSHTM) ‘Gender disparities in timely access to TB treatment’

Full panel Q&A session: Is there sexism in TB?

Session 3: Debate: Is migrant screening for LTBI worthwhile? (full session video)

Marc Lipman (UCL, chair)

Dominik Zenner (PHE) – for the motion

Christoph Lange (Borstel Research Centre) – against the motion

Q & A: Is migrant screening for LTBI worthwhile?

Session 4: What does TB elimination mean? (full session video)

Paul Fine (LSHTM, chair)

Anna Vassall (LSHTM) ‘TB elimination: Economic benefits and choices’

Rein Houben (LSHTM) ‘Modelling the Elimination of TB – bending the curve’

Mishal Khan (LSHTM) ‘Are global strategies to control TB optimally designed to meet disease reduction goals?’

Full Panel Q&A session: What does TB elimination mean?